Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
All acellular pertussis vaccines contain pertussis toxoid and induce protection against pertussis. This study investigated the relation between the postvaccination levels of pertussis toxin (PT) serum IgG and protection against pertussis. PT IgG was determined in sera obtained 21-77 days after the third vaccination from 813 children who received 3 doses of pertussis toxoid. The children were followed for 21-33 months after vaccination for the occurrence of pertussis. Of the children, 126 were exposed to pertussis in their households. The median PT IgG concentration was 79 U/mL in those who developed severe pertussis (>/=21 day of paroxysmal cough), 156 U/mL with mild pertussis (<21 days of paroxysmal cough), and 246 U/mL in those who did not develop pertussis (79 vs. 246, P<.0001). Corresponding values in the 687 children with no household exposure were 99, 124, and 155 U/mL, respectively (99 vs. 155, P<.0001). Thus, there is a highly significant correlation between the level of vaccine-induced serum PT IgG and protection against pertussis.
Taranger
J
J
Göteborg Pertussis Vaccine Study, Göteborg Primary Health Care System, S-416 60 Göteborg, Sweden.
Trollfors
B
B
Lagergård
T
T
Sundh
V
V
Bryla
D A
DA
Schneerson
R
R
Robbins
J B
JB
D000907:Antibodies, Bacterial / Q000097:blood*; D004311:Double-Blind Method; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D007223:Infant; D037342:Pertussis Toxin; D010567:Pertussis Vaccine / Q000276:immunology*; D013997:Time Factors; D014611:Vaccination; D010566:Virulence Factors, Bordetella / Q000276:immunology*; D014917:Whooping Cough / Q000517:prevention & control*
D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D010567:Pertussis Vaccine; D010566:Virulence Factors, Bordetella; D037342:Pertussis Toxin